Europe, the Middle East and Africa Insomnia Market 2022
Insomnia is a sleep disorder which can be caused by unhealthy sleep habits, specific substances, biological factors, psychiatric and medical conditions. Medical conditions that can cause insomnia are gastrointestinal problems, sinus, endocrine problems, arthritis, asthma, chronic pain and neurological disorders. Insomnia is found to be more prevalent in women as compared to men which can be due to stress. Insomnia can be treated by improving sleeping habits, cognitive behavior therapy and medications like sedatives, antihistamine and antidepressant. However, prolonged use of these medications can cause dependency and addiction hence needs to be taken under medical supervision. Insomnia can be diagnosed in sleep laboratories using various diagnostics devices.
The growing incidence of psychiatric conditions like clinical depression and neurological disorders favor the growth of this market. Additionally, work related stress, lifestyle changes, use of sleeping pill and other personal issues causes insomnia which leads to increase growth of this market. Lack of awareness about insomnia in some developing countries and side effects of certain treatment medications are major restraints in growth of insomnia market.
Europe, the Middle East and Africa Insomnia Market is expected to grow at a CAGR of 4.28% during forecasted period of 2017-2023.
Major Key Players:
Pfizer Inc. (U.S.), Sanofi (France), GlaxoSmithKline Plc. (UK), Astellas (UK), Biocodex S A (France), Teva (Israel), Neurim (Switzerland) are key players for Insomnia Market in Europe, the Middle East and Africa. Others players are Rythm (France), Flynn Pharma (U.K), Tabuk Pharmaceutical (Jordan), Actelion Pharmaceuticals (Switzerland) and CAD Middle East Pharmaceutical Industries LLC (Saudi Arabia) are some of the player at the forefront of the competition in insomnia market.
Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/europe-insomnia-market-594
Regional Analysis
Europe accounts for largest share in Europe, the Middle East and Africa Chronic Insomnia Market. France dominates the insomnia market in Europe. The Middle East is second growing market for insomnia. Africa is has the least market share in this market. Increasing prevalence of psychiatric and neurological conditions causing insomnia and hence increasing use of sleeping pills drives the insomnia diagnosis and treatment market in Europe, the Middle East and Africa.
Related Reports:
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
